BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25226239)

  • 1. Genetic prediction of antidepressant drug response and nonresponse in Korean patients.
    Lim SW; Won HH; Kim H; Myung W; Kim S; Kim KK; Carroll BJ; Kim JW; Kim DK
    PLoS One; 2014; 9(9):e107098. PubMed ID: 25226239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
    Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
    Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
    Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy.
    Pae CU; Serretti A; Mandelli L; De Ronchi D; Patkar AA; Jun TY; Kim JJ; Lee CU; Lee SJ; Lee C; Paik IH
    Pharmacogenet Genomics; 2007 Jan; 17(1):69-75. PubMed ID: 17264804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC17A7 gene may be the indicator of selective serotonin reuptake inhibitor treatment response in the Chinese Han population.
    Li X; Yu T; Huang X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; Lin Y; Li X; He L; Sun X; He G
    J Clin Psychopharmacol; 2014 Jun; 34(3):331-6. PubMed ID: 24743714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population.
    Zhang X; Yu T; Li X; Li X; Huang X; Li X; He L; He G; Sun X
    Pharmacopsychiatry; 2014 Mar; 47(2):60-6. PubMed ID: 24488700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine pathway polymorphisms and antidepressant response.
    Yin L; Zhang X; Huang Y; Sun X
    Asia Pac Psychiatry; 2016 Jun; 8(2):109-17. PubMed ID: 25854875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the TPH1 A218C polymorphism and antidepressant response: evidence from an updated ethnicity, antidepressant-specific, and ethnicity-antidepressant interaction meta-analysis.
    Zhao X; Huang Y; Li D; Han C; Kan Q
    Psychiatr Genet; 2015 Feb; 25(1):1-8. PubMed ID: 25419635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
    Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
    Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
    Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
    Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study.
    Perlis RH; Patrick A; Smoller JW; Wang PS
    Neuropsychopharmacology; 2009 Sep; 34(10):2227-36. PubMed ID: 19494805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment.
    Wang Y; Liu X; Yu Y; Han Y; Wei J; Collier D; Li T; Ma X
    Psychiatry Res; 2012 Dec; 200(2-3):1047-50. PubMed ID: 22796099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.